The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling
Open accessAbstract
The β-catenin signaling pathway is deregulated in nearly all colon cancers. Nonhypercalcemic vitamin D3 (1α,25-dehydroxyvitamin D3) analogues are candidate drugs to treat this neoplasia. We show that these compounds promote the differentiation of human colon carcinoma SW480 cells expressing vitamin D receptors (VDRs) (SW480-ADH) but not that of a malignant subline (SW480-R) or metastasic derivative (SW620) cells lacking VDR. 1α,25(OH)2D3 induced the expression of E-cadherin and other adhesion proteins (occludin, Zonula occludens [ZO]-1, ZO-2, vinculin) and promoted the translocation of β-catenin, plakoglobin, and ZO-1 from the nucleus to the plasma membrane. Ligand-activated VDR competed with T cell transcription factor (TCF)-4 for β-catenin binding. Accordingly, 1α,25(OH)2D3 repressed β-catenin–TCF-4 transcriptional activity. Moreover, VDR activity was enhanced by ectopic β-catenin and reduced by TCF-4. Also, 1α,25(OH)2D3 inhibited expression of β-catenin–TCF-4-responsive genes, c-myc, peroxisome proliferator-activated receptor δ, Tcf-1, and CD44, whereas it induced expression of ZO-1. Our results show that 1α,25(OH)2D3 induces E-cadherin and modulates β-catenin–TCF-4 target genes in a manner opposite to that of β-catenin, promoting the differentiation of colon carcinoma cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis
Gumbiner, B. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81279-9 · Cited by 3,471
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Self-citationParker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,003
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656
E-cadherin germline mutations in familial gastric cancer
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., & Reeve, A. E. (1998) · Nature · doi:10.1038/32918 · Cited by 1,656
Morphogenetic roles of classic cadherins
Takeichi, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80102-2 · Cited by 1,450
A causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,424
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
Functional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., & Birchmeier, W. (1998) · Science · doi:10.1126/science.280.5363.596 · Cited by 1,260
Wnt Signaling in Oncogenesis and Embryogenesis--a Look Outside the Nucleus
Peifer, M., & Polakis, P. (2000) · Science · doi:10.1126/science.287.5458.1606 · Cited by 1,253
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
He, T.-C., Chan, T. A., Vogelstein, B., & Kinzler, K. W. (1999) · Cell · doi:10.1016/s0092-8674(00)81664-5 · Cited by 1,085
BIRCHMEIER, W., & BEHRENS, J. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90003-5 · Cited by 1,002
Classification of human colorectal adenocarcinoma cell lines.
Leibovitz, A., Stinson, J. C., McCombs, W. B., McCoy, C. E., Mazur, K. C., & Mabry, N. D. (1976) · PubMed · Cited by 949
Cadherins in cancer: implications for invasion and metastasis
Takeichi, M. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90029-p · Cited by 923
Nuclear localization of β-catenin by interaction with transcription factor LEF-1
Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., & Kemler, R. (1996) · Mechanisms of Development · doi:10.1016/0925-4773(96)00597-7 · Cited by 856
The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene
Christofori, G., & Semb, H. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01343-7 · Cited by 742
Mutations in the APC tumour suppressor gene cause chromosomal instability
Fodde, R., Kuipers, J., Rosenberg, C., Smits, R., Kielman, M., Gaspar, C., van Es, J. H., Breukel, C., Wiegant, J., Giles, R. H., et al. (2001) · Nature Cell Biology · doi:10.1038/35070129 · Cited by 723
SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY
Garland, C., Garland, F., Shaw, E., Comstock, G., Helsing, K., & Gorham, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91789-3 · Cited by 678
The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
Crawford, H. C., Fingleton, B. M., Rudolph-Owen, L. A., Goss, K. J. H., Rubinfeld, B., Polakis, P., & Matrisian, L. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202627 · Cited by 673
Mann, B., Gelos, M., Siedow, A., Hanski, M. L., Gratchev, A., Ilyas, M., Bodmer, W. F., Moyer, M. P., Riecken, E. O., Buhr, H. J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1603 · Cited by 663
A role for the Adenomatous Polyposis Coli protein in chromosome segregation
Kaplan, K. B., Burds, A. A., Swedlow, J. R., Bekir, S. S., Sorger, P. K., & Näthke, I. S. (2001) · Nature Cell Biology · doi:10.1038/35070123 · Cited by 545
Regulation of LEF-1/TCF transcription factors by Wnt and other signals
Eastman, Q., & Grosschedl, R. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80031-3 · Cited by 540
van de Wetering, M., Oosterwegel, M., Dooijes, D., & Clevers, H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07928.x · Cited by 538
Orsulic, S., Huber, O., Aberle, H., Arnold, S., & Kemler, R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.8.1237 · Cited by 534
Kishida, S., Yamamoto, H., Ikeda, S., Kishida, M., Sakamoto, I., Koyama, S., & Kikuchi, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10823 · Cited by 491
Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover
Henderson, B. R. (2000) · Nature Cell Biology · doi:10.1038/35023605 · Cited by 473
Synergy Between Tumor Suppressor APC and the β-Catenin-Tcf4 Target Tcf1
Roose, J., Huls, G., Beest, M. V., Moerer, P., Horn, K. V. D., Goldschmeding, R., Logtenberg, T., & Clevers, H. (1999) · Science · doi:10.1126/science.285.5435.1923 · Cited by 456
Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K., & Kato, S. (1999) · Science · doi:10.1126/science.283.5406.1317 · Cited by 445
The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression
Balda, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.2024 · Cited by 443
Expression of CD44 in Apc and TcfMutant Mice Implies Regulation by the WNT Pathway
Wielenga, V. J. M., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., & Pals, S. T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65297-2 · Cited by 433
Gottardi, C. J., Arpin, M., Fanning, A. S., & Louvard, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10779 · Cited by 367
The Wnt/Wg Signal Transducer β-Catenin Controls Fibronectin Expression
Gradl, D., Kühl, M., & Wedlich, D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5576 · Cited by 355
Watabe-Uchida, M., Uchida, N., Imamura, Y., Nagafuchi, A., Fujimoto, K., Uemura, T., Vermeulen, S., van Roy, F., Adamson, E. D., & Takeichi, M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.847 · Cited by 348
The APC tumour suppressor has a nuclear export function
Rosin-Arbesfeld, R., Townsley, F., & Bienz, M. (2000) · Nature · doi:10.1038/35023016 · Cited by 343 · cited 2×
“…to the blockade of phosphorylation by GSK-3 , resulting in -catenin stabilization (Inomata et al., 1996; Korinek et al., 1997; Morin et al., 1997), reduced APC-regulated nuclear export (Henderson, 2000; Rosin-Arbesfeld et al., 2000), and perhaps higher specific activity (Guger and Gumbiner, 2000).”
BackgroundRajasekaran, A. K., Hojo, M., Huima, T., & Rodriguez-Boulan, E. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.3.451 · Cited by 339
Díaz, G. D., Paraskeva, C., Thomas, M. G., Binderup, L., & Hague, A. (2000) · PubMed · Cited by 315
Vennström, B., & Michael Bishop, J. (1982) · Cell · doi:10.1016/0092-8674(82)90383-x · Cited by 310
Cross-regulation of β-catenin–LEF/TCF and retinoid signaling pathways
Easwaran, V., Pishvaian, M., Salimuddin, & Byers, S. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80088-3 · Cited by 229
Wnt/β-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine
Lickert, H., Domon, C., Huls, G., Wehrle, C., Duluc, I., Clevers, H., Meyer, B. I., Freund, J.-N., & Kemler, R. (2000) · Development · doi:10.1242/dev.127.17.3805 · Cited by 226
Kolligs, F. T., Kolligs, B., Hajra, K. M., Hu, G., Tani, M., Cho, K. R., & Fearon, E. R. (2000) · Genes & Development · doi:10.1101/gad.14.11.1319 · Cited by 222
Billin, A. N., Thirlwell, H., & Ayer, D. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6882-6890.2000 · Cited by 216
Inhibition of β-catenin-mediated transactivation by cadherin derivatives
Sadot, E., Simcha, I., Shtutman, M., Ben-Ze’ev, A., & Geiger, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15339 · Cited by 216
Koh, T. J., Bulitta, C. J., Fleming, J. V., Dockray, G. J., Varro, A., & Wang, T. C. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9476 · Cited by 209
TREATMENT OF EARLY RECURRENT PROSTATE CANCER WITH 1,25-DIHYDROXYVITAMIN D3 (CALCITRIOL)
GROSS, C., STAMEY, T., HANCOCK, S., & FELDMAN, D. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63236-1 · Cited by 206
Inomata, M., Ochiai, A., Akimoto, S., Kitano, S., & Hirohashi, S. (1996) · PubMed · Cited by 193
Zhurinsky, J., Shtutman, M., & Ben-Ze'ev, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4238-4252.2000 · Cited by 185
VDR-Alien: a novel, DNA-selective vitamin D3 receptor-corepressor partnership
POLLY, P. (2000) · The FASEB Journal · doi:10.1096/fj.14.10.1455 · Cited by 177
Shabahang, M. M., Buras, R., Davoodi, F., et al. (1993) · PubMed · Cited by 176
Hmama, Z., Nandan, D., Sly, L., Knutson, K. L., Herrera-Velit, P., & Reiner, N. E. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1583 · Cited by 175
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
Smith, D. C., Johnson, C. S., Freeman, C. C., et al. (1999) · PubMed · Cited by 175
Duval, A., Rolland, S., Tubacher, E., Bui, H., Thomas, G. D., & Hamelin, R. (2000) · PubMed · Cited by 171
Gulliford, T., English, J., Colston, K., Menday, P., Moller, S., & Coombes, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.434 · Cited by 164
Calcium, vitamin D, and colon cancer.
Lipkin, M., Newmark, H., Boone, C. W., & Kelloff, G. J. (1991) · PubMed · Cited by 155
Koli, K., & Keski‐Oja, J. (2000) · PubMed · Cited by 148
Expression of occludin, tight-junction-associated protein, in human digestive tract.
Kimura, Y., Shiozaki, H., Hirao, M., Maeno, Y., Doki, Y., Inoue, M., Monden, T., Ando‐Akatsuka, Y., Furuse, M., Tsukita, S., et al. (1997) · Europe PMC (PubMed Central) · doi:10.11501/3143867 · Cited by 146
Nuclear receptors and genetic disease
Burris, T. P., & McCabe, E. R. B. (2001) · Cited by 114
Thomas, M. G., Tebbutt, S. J., & Williamson, R. C. (1992) · Gut · doi:10.1136/gut.33.12.1660 · Cited by 112
Gniadecki, R., Gajkowska, B., & Hansen, M. (1997) · Endocrinology · doi:10.1210/endo.138.6.5156 · Cited by 93
Zhao, X., & Feldman, D. I. (1993) · Endocrinology · doi:10.1210/endo.132.4.8384998 · Cited by 92
Evans, S. R. T., Nolla, J. M., Hanfelt, J., Shabahang, M. M., Nauta, R. J., & Shchepotin, I. B. (1998) · PubMed · Cited by 92
Transcriptional Targets of the Vitamin D3 Receptor–Mediating Cell Cycle Arrest and Differentiation
Freedman, L. P. (1999) · Journal of Nutrition · doi:10.1093/jn/129.2.581s · Cited by 91
Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin
Mareel, M., Bracke, M., & Roy, F. M. V. (1994) · Molecular Biology Reports · doi:10.1007/bf00987321 · Cited by 85
1α,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cellsin vitro
Hansen, C. M., Frandsen, T. L., Brünner, N., & Binderup, L. (1994) · Clinical & Experimental Metastasis · doi:10.1007/bf01753887 · Cited by 82
Schwarte‐Waldhoff, I., Klein‐Scory, S., Blass-Kampmann, S., Hintelmann, A., Eilert-Micus, C., Dreschers, S., Kalthoff, H., Hahn, S. A., & Schmiegel, W. (1999) · Oncogene · doi:10.1038/sj.onc.1202641 · Cited by 81
Tong, W., Kállay, E., Hofer, H., Hulla, W., Manhardt, T., Peterlik, M., & Cross, H. S. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00267-6 · Cited by 81
1,25-Dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues
Vandewalle, B., Adenis, A., Hornez, L., et al. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90181-3 · Cited by 78
Eleftheriou, A., Yoshida, M., & Henderson, B. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102656200 · Cited by 75
Park, W. H., Seol, J. G., Kim, E. S., Jung, C. W., Lee, C. C., Binderup, L., Koeffler, H. P., Kim, B. K., & Lee, Y. Y. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4735 · Cited by 70
A Mode of Regulation of β-Catenin Signaling Activity in Xenopus Embryos Independent of Its Levels
Guger, K. A., & Gumbiner, B. M. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9770 · Cited by 65
Pan, Q., & Simpson, R. U. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8437 · Cited by 55
1,25‐Dihydroxyvitamin D3 inhibits tenascin‐C expression in mammary epithelial cells
González‐Sancho, J. M., Álvarez‐Dolado, M., & Múñoz, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00348-2 · Cited by 52
Kawasoe, T., Furukawa, Y., Daigo, Y., Nishiwaki, T., Ishiguro, H., Fujita, M., Sato, S., Miwa, N., Nagasawa, Y., Miyoshi, Y., et al. (2000) · PubMed · Cited by 37
Jimenez-Lara, A. M., & Aranda, A. (1999) · Endocrinology · doi:10.1210/en.140.6.2898 · Cited by 27
Baulida, J., Batlle, E., & de Herreros, A. G. (1999) · Biochemical Journal · doi:10.1042/bj3440565 · Cited by 17
Self-citationMacDonald, P. N., Kraichely, D. M., & Brown, A. J. (2001) · Elsevier eBooks · doi:10.1016/b978-012146160-7/50007-x · Cited by 6
(1999) · doi:10.1002/(sici)1521-1878(199912)22:1<1021::aid-bies6>3.0.co;2-p
Cited by
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., & Carmeliet, G. (2016) · Physiological Reviews · doi:10.1152/physrev.00014.2015 · Cited by 1,957
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0004 · Cited by 1,783
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Deeb, K. K., Trump, D. L., & Johnson, C. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2196 · Cited by 1,419
Metadata
- Authors
- Pálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., Quintanilla, M., Cano, A., de Herreros, A. G., Lafarga, M., & Muñoz, A.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2001-07-16
- Volume
- 154
- Issue
- 2
- Pages
- 369-388
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2138153315
- Cited by
- 802
- References
- 85
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.